LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)

Clinical trial NCT00160589 · COMPLETED

Trial details

NCT number: NCT00160589
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rhinitis, Allergic, Perennial

Start date: 2005-04-01
Primary completion: 2005-09-01
Enrollment: 729

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.